title: Does metabolic failure at the synapse cause Alzheimer's disease?
abstract: Alzheimer's disease (AD) a neurodegenerative disorder of widely distributed cortical networks evolves over years while A beta (Aβ) oligomer neurotoxicity occurs within seconds to minutes. This disparity combined with disappointing outcomes of anti-amyloid clinical trials challenges the centrality of Aβ as principal mediator of neurodegeneration. Reconsideration of late life AD as the end-product of intermittent regional failure of the neuronal support system to meet the needs of vulnerable brain areas offers an alternative point of view. This model introduces four ideas: (1) That Aβ is a synaptic signaling peptide that becomes toxic in circumstances of metabolic stress. (2) That intense synaptic energy and maintenance requirements of cortical hubs may exceed resources during peak demand initiating a neurotoxic cascade in these selectively vulnerable regions. (3) That axonal transport to and from neuron soma cannot account fully for high mitochondrial densities and other requirements of distant terminal axons. (4) That neurons as specialists in information management, delegate generic support functions to astrocytes and other cell types. Astrocytes use intercellular transport by exosomes and tunneling nanotubes (TNTs) to deliver mitochondria, substrates and protein reprocessing services to axonal sites distant from neuronal soma. This viewpoint implicates the brain's support system and its disruption by various age and disease-related insults as significant mediators of neurodegenerative disease. A better understanding of this system should broaden concepts of neurodegeneration and facilitate development of effective treatments.
authors.affiliation: Geriatric Research, Education and Clinical Center, VA Boston Healthcare System, Harvard Medical School, United States. Electronic address: peter.engel@va.gov.
authors.forename: Peter A
authors.initials: PA
authors.lastname: Engel
mesh_terms: D000375:Aging; D000544:Alzheimer Disease / Q000378:metabolism* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000737:chemistry*; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001369:Axons / Q000378:metabolism; D001921:Brain / Q000502:physiology; D001931:Brain Mapping; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D008959:Models, Neurological; D043942:Nanotubes / Q000737:chemistry; D009474:Neurons / Q000378:metabolism; D009836:Oligodendroglia / Q000378:metabolism; D010455:Peptides / Q000737:chemistry; D015398:Signal Transduction; D013312:Stress, Physiological; D013569:Synapses / Q000378:metabolism*
chemical_list: D016229:Amyloid beta-Peptides; D010455:Peptides